SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as community members rally behind the stock, fueled by potential catalysts like a new CEO announcement and optimism around future interest rate cuts. The stock's recent surge has sparked discussions of a potential short squeeze and gamma squeeze, with retail investors expressing strong bullish sentiment. A well-known celebrity recently announced their support of $OPEN adding fuel to the fire.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a land sale agreement potentially boosting its NAV, attracting attention for its small float and potential for a significant upward move. Community discussions highlight the possibility of a short squeeze, comparing it to other recent low float runners. The stock's low float and increasing volume are key talking points.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending amid community excitement for upcoming developments, including a staking app and potential token burns upon reaching new watcher milestones. The community emphasizes its strong synergy and the consistent efforts of the developers, contrasting it with other projects in the crypto space. Many community members express bullish sentiment, anticipating further growth and a climb back to the top trending spot.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid speculation of a potential acquisition following leadership changes, with Nestle being a frequently mentioned suitor. Community discussions focus on the possibility of a merger or strategic partnership to bolster the company's finances and pipeline. The stock's high short interest and low float are also fueling hopes for a potential short squeeze.

Forward Industries, Inc. engages in the provision of integrated design, development, and manufacturing solutions for top tier medical and technology customers worldwide. It operates through the following segments: OEM Distribution, Retail Distribution, and Design. The OEM Distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. The Retail Distribution segment sells smart-enabled furniture and a variety of other products through agreements with various retailers, both in stores and through online retailer websites. The Design segment provides hardware and software product design and engineering services. The company was founded in 1961 and is headquartered in Hauppauge, NY.

Forward Industries, Inc.

Forward Industries ($FORD) is trending due to a potential sympathy play with $AREB and recent compliance news, sparking interest in its low float. However, some traders are mistaking it for Ford Motor Company ($F), leading to speculative trading. The community is discussing its potential for a parabolic breakout, while cautioning against being a bag holder.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community anticipates upcoming earnings, speculating on profitability and potential impacts from new ventures like trading cards and the collectibles market. Some traders are weighing the possibility of a Roaring Kitty return, while others debate the stock's long-term prospects and the potential for market manipulation. There's also discussion of a possible Lego partnership and its impact on revenue.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending as investors react to recent strong revenue growth and a major contract win with the German government, sparking discussions about potential for further gains. The community is closely watching margins and upcoming earnings, with some anticipating a buyout or major partnership announcement given the unusual choice to hold the earnings call at the NYSE. Despite positive developments, volatility remains a concern due to the stock's small-cap tech exposure.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoin is trending as the community debates its potential amid discussions around privacy and regulatory concerns, with some bullish investors pointing to institutional accumulation and the project's connection to Sam Altman. Chatter includes speculation on price targets and breakout potential, while others remain skeptical of its use case and tokenomics. The project's biometric data collection and recent developments, like expansion into new regions, are also being actively discussed.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's potential S&P 500 inclusion is the hot topic, driving significant overnight gains and speculation about future growth. The community is weighing the potential for institutional investment against the possibility of a "sell the news" event, with some anticipating a continued climb while others foresee a short-term pullback. Discussions also include the impact of prediction markets and upcoming events on HOOD's trajectory.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as investors weigh the potential impact of economic data and Fed policy on bond yields; community discussions focus on whether recent market moves signal a shift in the bond market or a buying opportunity. Ongoing tariff debates and concerns about Fed independence add to the ETF's volatility. Some traders are betting on a near-term bounce, while others anticipate a decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JPM downgrades Avis Budget after stock rally on recall, tariff impact

Investing.com -- JP Morgan downgraded  Avis Budget  (NASDAQ:CAR) Group to Neutral from Overweight, saying the stock’s sharp rally since March has outpaced the underlying earnings outlook, while near-term pressures from safety recalls and fading tariff tailwinds weigh on estimates.

These companies are most likely to surprise in real estate H1 earnings season

Investing.com -- Bernstein expects a mixed but potentially positive first-half earnings season for the European real estate sector, highlighting nine companies that could raise their guidance.

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference PR...

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference...

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline PR Newswire PHILADELPHIA, Dec. 9...

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting 2024

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting 2024 Carisma Therapeutics Presents Promising New...

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR...

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for...

Carisma Therapeutics Announces Changes to its Board of Directors

Carisma Therapeutics Announces Changes to its Board of Directors Carisma Therapeutics Announces Changes to its Board of Directors PR Newswire PHILADELPHIA, Oct. 30, 2024 Appointment of Sohanya Cheng...

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 PR Newswire PHILADELPHIA, Oct. 4, 2024 PHILADELPHIA, Oct. 4, 2024...

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Current Price	$0.4019
Prev Close	$0.32
Open	$0.3139
Dividend Yield	0.00%
50-Day Moving Average	$0.3376
Beta	1.21
Avg. Volume	4.8M
PE Ratio	-0.34

52-Week High	$1.27
52-Week Low	$0.1417
Market Capitalization	$16.79M
EPS (Annual)	-$1.46
Price to Book	-0.37
Revenue Per Employee	$426,782.61
Enterprise Value/EBITDA	N/A

CARM
Carisma Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CARM News

CARM Carisma Therapeutics Inc